Archived Headlines
March 12, 2010
Industry Group Says Feds Content With FEHBP Drug Benefits
Democrats Pare Differences Over Health Overhaul
UPDATE: Democrats Poised To 'Finish The Job' On Health Care
Health care partisans line up to lobby
March 11, 2010
Specialty Groups Oppose Reform Bill; AMA To Stay 'Engaged'
Pharmaceutical group spent $6.3M lobbying in Q4
Lawmakers put the 'dead' in health-care reform deadline
Senate GOP: No Easy Way Forward on Health Bill
March 10, 2010
Health-care reform's sickeningly sweet deals
Business groups launch ad against health care bill
Why Health Care Costs Keep Rising: What You Need to Know
Why Obama Can't Move the Health-Care Numbers
Obama pushing on health care end game
March 9, 2010
New York Times Provides Soapbox for Data Exclusivity Critics
Drug Companies Go Head-to-Head
Obama and pals push back on health care
Obama back on the campaign trail, this time for health care
March 8, 2010
Biologics Boondoggle
Biosimilars could bring down specialty drug spending
The Challenge of Defining the Higher Order Structure of Biopharmaceutical Products
Votes uncertain as healthcare endgame looms
Democrats Voice Health-Bill Doubts
March 5, 2010
Messing Up The FEHBP: More Proof That Americans Can’t Trust Congress With Health Care
Obama Meets With Targeted Moderates
GOP Mounts Message Offensive to Defeat Health Care
Democratic leaders working to win over abortion opponents for health-care reform
Obama intensifies health-care efforts
March 4, 2010
Obama Calls for Reconciliation to Prevent Filibuster on Health-Care Reform
Senate Moderates Warm to Reconciliation
Some Dems are Wary of Obama’s Final Health Push
Obama Sets Timetable, But Obstacles Continue Mounting
March 3, 2010
Democrats Chase Health Votes
Democrats Eye Health Care Finish
Drugmakers Ask FDA to Reconsider Social Media Policy for Drug Risks
The President vs. Health-Care Reform
March 2, 2010
Specialty Drugs Force High Medicare Out-Of-Pocket Costs
Francis: ‘Where’s the Beef’ in Claims That Employee Health Plans Overspend on Drugs?
Battle Brews Over Tactic to Win Passage of Health Bill
Obama to Highlight Cost in New Health Bill Push
GOP Girding for Battle Over Reconciliation
March 1, 2010
Democrats will have votes for health bill, Obama aide says
White House: Simple Up or Down Vote on Health Care
Pelosi Confident on Health Vote
Democrats Ready to Flex Majority Muscle
Stark To Use GAO Specialty-Tier Drug Report In Press For Doughnut Hole Closure
February 26, 2010
Q. As a federal worker, are you satisfied with your health care, including the prescription drug benefit?
White House Healthcare Summit Debates Medicare Part D Gap
More Talk, No Deal at Health Summit
Republicans on health care: Let's start over
A ‘Government Takeover’ of Health Care?
February 25, 2010
Why do pharmacy owners care about PBM transparency?
OPM opposes bill to increase transparency in drug pricing
Gibbs Wants Productive Health Care Talks Thursday
Republicans to Offer Health Plans at Summit
What the GOP Should Say at the Health Summit
February 24, 2010
Officials question need for bill to boost prescription drug oversight
Bill seeks transparency in employees' health program
Here’s the Rx for a Bipartisan Health Care Reform Bill
Most Americans still think overhaul needed, poll says
Republicans plan to stress private-sector alternatives to the president's plan
February 23, 2010
Don't Expect Miracles From Health Confab
For Health Care Summit to Succeed, Go Step-by-Step
White House tilts at barrier to cheap drugs
Doctor Training Aided by Drug Industry Cash
PhRMA’s Deal May Evaporate, Annual Fees Remain in Obama Health Proposal
February 22, 2010
The World's Most Expensive Drugs
How the G.O.P. Can Fix Health Care
Ethics push has effect: Lobbyist spending drops
White House Will Release Health Reform Plan Ahead Of Bipartisan Summit
Republicans Skeptical of Health Summit but Claim Willingness to Deal
February 19, 2010
Follow-On Biologics Politics: AARP's Rother Explains "What Beat Us"
Once More, Health Care Cost Control
Generic CEOs, AARP: Low Costs Can’t Be Generics’ Only Biosimilars Message
AARP Says Congress To Tackle Drug Prices Even If Reform Dies
Reviving the Health-Care Debate
February 18, 2010
Generic-Drug Makers See Piecemeal Legislation as Possible
Even Me-Too Drugs Get The Blues
Top Democrats Can’t Say How Health Care Reform Will Get Done
February 17, 2010
Poll: Start over on health reform
Database Gives Snapshot of Health in Each County
GOP sees possible upside in health care summit
Reconciliation Alive Despite Health Care Summit
February 16, 2010
Uncle Sam wants you to use mail-order pharmacy
Drug Firms Apply Brand to Generics
GOP, Expecting Little, Will Attend Health Summit
Private drug tester expands stake in Big Pharma
February 15, 2010
Wanted: Ex-Congressman. Must Love Drugs. Good Pay
Management, Press Flap Led to Tauzin’s Exit
Follow-On Biologics One Possible Fruit Of FDA-Northeastern Collaboration
Drug Industry Signals Lobbying Shift
CEO Blog: Despite Setbacks, Congress Should Approve a U.S. Biogenerics Pathway
February 12, 2010
PhRMA President Tauzin to Resign
BIO-Backed Group Urges HHS To Reject Panel’s Genetics Proposals
What Is ‘Affordable’ Health Care?
The Lobbying-Media Complex
February 11, 2010
Merritt: Congress Considering Risky Changes to Federal Employees’ Health Benefits
Pelosi Aide Outlines Healthcare Endgame
No Real New Money for Drug Regulation
Other insurers raising health care rates too
A Simple Health-Care Fix Fizzles Out
February 10, 2010
Follow-on biologics present opportunity to big pharma
Ten GOP Health Ideas for Obama
Dems, GOP gear up for health care summit on TV
Generic drugs sales continue to climb
February 9, 2010
Law Review: Health-care debate is good business for lobbyists
GOP wary of pitfalls in Obama's health care summit
Small Business Group Continues Press For Help With Health Costs
GOP Fears Obama’s Health Summit Is a Trap
February 8, 2010
The Economics of Biologics
Sen. Baucus Dismisses Need To Compromise On Health Care Reform
Teva Settles Drug-Pricing Lawsuits
Obama invites Republicans to summit on health care
February 5, 2010
Sebelius Highlights Inspections, Biosimilars in Congressional Testimony
Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
White House Small Business Plans May Bolster Device, Biotech Innovation
Obama suggests Republicans could have a role in health-care bill
FDA Budgets $6 Million To Prepare For Biosimilars, With Or Without A Bill
February 4, 2010
Obama suggests Republicans could have a role in health-care bill
Report: Feds to Pay More Than Half of Health Costs
Health Official Can’t Guarantee Openness in Talks
Soaring cost of healthcare sets a record
What Happens If Nothing Happens to Health Care?
February 3, 2010
The Influence Game: Health lobbying gears down
Pharma to pay under Obama tax plan
Democrats Change Health-Care Tack
Food safety, drug access top FDA concerns
FDA Focuses on Postmarket Safety in 2011 Budget Request
February 2, 2010
Obama budget plan calls for generic drugmaker fees
Obama Says He’s Counting on GOP Support on Health Care
FDA Biosimilars Program Gets Seed Money In Administration's FY '11 Budget
Health Care and the Deficit
Obama Tells House GOP That Administration Had Been 'Scrubbing' Health Reform Provisions That Violated His Pledge
February 1, 2010
Pro or Con, Lobbying Thrived
Reform — All Over but the Lobbyin’?
GOP and Democrats Agree Health Overhaul Not Dead
Analysis: Dems' Missteps Led to Health Breakdown
Obama Tells House GOP That Administration Had Been 'Scrubbing' Health Reform Provisions That Violated His Pledge
January 29, 2010
Drugstore Owners Look to Cash in on Health Care Reform
Drugmakers Post Higher Sales but a Mix on Profits
Senate Dem: Health care bill 'on life support'
Generics, Biologics, And Other Industrywide Trends
Overhaul Debate Brings Together Cross-Capitol Moderates
January 28, 2010
Waxman Requests Information on White House Deals
Health Care Gives Way
Obama’s Address: Reaffirming Promise on Health Care
Obama tries to salvage health care bill
FDA to Study Bioequivalence of Generic, Brand Drugs Soon
January 27, 2010
Backroom Health Care Deals Fuel Voter Anger
Democrats Slow Efforts on Health
‘No Rush’ on Health Care Overhaul, Democrats Say
Few like Congress’ work on health care
With Health Care Reform In Doubt, Drug Pricing Remains Uncertain Too, Execs Note
January 26, 2010
Law Professors Contend that Data Exclusivity Is Secondary Issue in FOB Debate
Carcieri fights for biologics protections
Way forward on health care
Pharma plowed millions into Q4 lobbying
Health Reform Bill Downsizing Would Send Pharma Back To Bargaining Table
January 25, 2010
Pass the Popular Parts of Health Care Reform and Ditch the Rest
Too Big to Reform
Who stands to benefit from health-care reform?
BioWatch: Federal biosimilar regulation gathers support
The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
January 22, 2010
Analysis: Paring Back Health Care Not So Easy
Poll: Regroup on health care, most say
California leaders make an ill-timed lobbying trip to Capitol Hill
Dean: Dems Can Pass Limited Health Care Overhaul
Pelosi: House won't pass Senate bill to save health-care reform
January 21, 2010
Governors Write President in Support of 12-Year Data Exclusivity Period
Why it's so hard to pass health-care reform
Leaders Assess Health Reform Options
2009 was a mixed year for lobbying firms, early reports indicate
Experts: Drug Industry May Support Move to Preserve Senate Healthcare Bill
January 20, 2010
Governors protest Obama's move on generic drugs
Drug Companies and a Pivotal Senate Race Help Lead the Markets Higher
Republican win in Mass. could derail a biotech victory
Now Pfizer & Teva Are (Reportedly) Bidding Against Each Other
Moderate Democrats Seek 'Fail Safe' Mechanism In Health Reform Bill
January 19, 2010
Obama battles Congress and PhRMA over biogenerics
Biotech group may back Brown
Obama at odds with some Dems on key provision in healthcare
Data Exclusivity Follow-up: More of the Same
Snatching Defeat from the Jaws of Victory?
January 15, 2010
Biologic Drugs May Get Less Protection
Health Care: Is Obama Taking on the Biotech Industry?
An 11th-Hour Battle Over Biogenerics In Congress
Democrats Seek Added $10 Billion From Drug Firms
Health talks in overdrive with Obama pushing
January 14, 2010
Interest Groups Prep for Health Endgame
Drugmakers Asked For $10 Billion More
Groups' priority: Affordable care
FTC Presses Congress to Include Pay-for-Delay Ban in Healthcare Bill
Lawmakers Seek More Money From Drug, Device, Other Stakeholders To Fund Health Reform
January 13, 2010
Big Pharma, Generic Competition and Cash
FDA Aims for Transparency With New Web Site
Health-reform headaches the Democrats don't need
FDA takes drug makers to task on ads
Follow-on Biologic's Day Will Come - Post 2015, Teva Says
January 12, 2010
US GAO finds "extraordinary" increases in drug prices
Will overhaul put the brakes on health care costs?
Road Map: Health Deal-Making Kicks Off
Industry Protests GAO Report on Skyrocketing Brand Drug Prices
Biosimilars Law Likely In 2010, But Implementation May Lag For Years
January 11, 2010
Democrats are ready to compromise to get health reform done
How would a new health insurance pool work?
House Lawmakers Return to Focus on Jobs, Health Care
Many Major FDA Issues Were Resolved In ’09, But Big Challenges Remain
Insurance Lobby Outlines Changes It Wants In Senate Fee
January 8, 2010
Millions lose health care, access, group says
Nelson to Fight for All States
The Latest Deal in the Big Pharma-Generics Wars
Where U.S. Health Care Ranks Number One
Insurance Lobby Outlines Changes It Wants In Senate Fee
January 7, 2010
Why Drug 'Reimportation' Won't Die
AARP Lobbies Against Independent Medicare Advisory Board As Conferencing Begins On Health Care Bill
How interest groups behind health-care legislation are financed is often unclear
Pelosi Says Congress Close to Health Deal
House, Senate Must Reconcile Slew Of Medicare/Medicaid Policies
January 6, 2010
Pfizer: Playing At The No-Limit Table
C-SPAN pleads with Reid, Pelosi to open final drafting sessions for Obama's healthcare bill
Obama prods Congress to pass health bill quickly
Health Outlays Slow
Union-Backed Group Starts New Health Care Ad Campaign
January 5, 2010
Scrutiny of Drug-Industry Gifts to Docs Goes Global
Democrats Look to Scrap Conference to Ease Passage of Health Care Bill
2010: The Year Of Selling Health Care Reform
FDA's DTC Survey Tweaked At PhRMA's Suggestion
Health Reform Ban On Sale Of Rx Drug Information Out, Federal Study Possible
January 4, 2010
Our view on medical legislation: Don’t trust states to create health care exchanges
Really Big Money Politics
Health-care reform not finished yet
With Some Rx Tweaks, Senate Bill Moves To Conference With House
Generics Industry Faces Five Major Challenges, Actavis CEO Says (We're Partly Responsible For One Of Them, He Acknowledges)
December 23, 2009
Drug Industry Girds for Rise in Its Share of Overhaul
Polls: Majority Disapprove of Health Care Legislation
Senate Democrats Move Closer to Passing Health Care Reform
Dr. Reddy's Has All Guns Blazing On Biosimilars; Plans To Go After Top 10
PhRMA: There Is No New Part D Doughnut Hole Deal
December 22, 2009
Senate Democrats Clear Health Hurdle
Lobbyists on pace for record year
Are Progressives "Special Interests Who've Prevented Health Care Reform for Decades"?
GOP Senator: Democratic Health Care Deals 'Sleazy'
Extra $20 Billion PhRMA Cut, PBM Tax Not in Reid Package; May Be On Deck
December 18, 2009
Wall Street Speaks: Eshoo Block Biologics
It's now Democrat vs. Democrat on health care
Prescriptions: Nelson is Last Big Senate Holdout
PhRMA Denies Deal to Increase Its $80 Billion Agreement
Generics, Allies Launch Ads Seeking New Biosimilars Policy In Reform
December 17, 2009
Biotech bonanza lurks in healthcare reform bills
Senate plan is called too empowering to health insurers
Democrats vow to close Medicare 'doughnut hole'
Patent Reform Efforts Opposed by Small Business Group
Talk Of Annual Fee Worries Pharmacy Benefit Managers
December 16, 2009
Amidst the Lieberman Drama, Some Wrangling Over Drug Prices
If Health Care Reform Fails, America’s Innovation Gap Will Grow
Pfizer Eyes China Growth
Democrats Urged to Act on Health
Teva seeks closer ties with Lonza on biogenerics
December 15, 2009
Shhhh! Owning a Pharmacy is Very Profitable
Drugmakers fight plan to allow imports
Drug makers quicker to embrace settlements to delay low-cost generics
Senate Democrats Split On Prescription Drug Imports
Small businesses stand to benefit from proposed health care bills
December 14, 2009
Pharmacies Wary Of Jan. 1 Change To Part D Drug Coverage Policy
Liberals, Doctors: No Reform Deal
Obama, Democrats waiting for Nelson on health care
More companies are disclosing their political activity
Drugmakers' support for health overhaul tested
December 11, 2009
Lowering Prescription Costs, Enhancing Access and Improving Quality
Drug import amendment halts health debate
Guest column: Pharmacy lobby limits access to lifesaving drugs
AARP draws political fire
Patients first
December 10, 2009
Confusion Over ‘Deal’ Continues
Expert: Conflict-of Interest Probes May Shift Drugmaker Funding
Showdown vote nears on importing low-cost drugs
Health reform bills would set approval path for generic biologics
FDA Launches Orphan Drug Workshops
December 9, 2009
Eshoo Defends Biosimilar Legislation
Brown May Offer Proposal To Cut Exclusivity For Blockbuster Biologics
Finding the Nerve to Cut Health Costs
Obama’s War Plan Gains Amid Doubts on Domestic Policy (Update1)
PhRMA: Drug Price Increases Don’t Anticipate Healthcare Legislation
December 8, 2009
Eshoo bill huge boon for Silicon Valley biotech
Lieberman Skips Health Talks
Introducing the $30,000 Per Month Cancer Drug
Inside a U.S. healthcare "island of excellence"
Grassley Seeks Details on Medical Financing
December 7, 2009
Senators Propose Pay-for-Delay, Reimportation Healthcare Amendments
Drugmakers' Support for Health Overhaul Tested
Pharma Should Expect Heavier Taxes & Plan Accordingly, PwC Report Says
The True Costs Of Reform
A Rare Opportunity? FDA Orphan Products Head Makes The Case For More Big Pharma Investment In Rare Diseases
December 4, 2009
Why Biologics Remain Expensive
Two Physicians Want Congress to Close "Evergreening" Loophole in FOB Legislation
Health Reform Bills Differ On Key Details In Drug, Device Provisions
'Doughnut hole' unites seniors wary of health bill
Paying for Health Care (and War, by the Way)
December 3, 2009
Where Did Health Care Reform Go?
PhRMA Calls Sen. Nelson’s Healthcare Amendment ‘Line in Sand’
Health Reform Bills Differ On Key Details In Drug, Device Provisions
CBO Report Details Drugmakers’ Promotional Spending Habits
Generics law for new class of drugs is needed in health care reform
December 2, 2009
Nelson Will Offer Amendment Breaking PhRMA Deal
Opinion: Eshoo needs to close loophole in biologics legislation
Health Bill Would Impact Food, Drug Industries
UPDATE 2-U.S. senator: reform cost for pharma may be higher
Pfizer CEO: Health-Care Reform Very Important
December 1, 2009
Brand biologic developers: Poised for victory?
The Fight For Biogenerics
Deluge of Lobbying to Hit Senate
Health-Insurance Costs Won’t Rise for Most in U.S., Study Finds
Millions may be paying too much for drugs
November 30, 2009
Seven Things You Didn't Know Were In The Senate Health Bill
Drug law change could save patients big bucks
Brand 'Biologics' Retain Edge in Bills
Big Pharma Sells Out
How Will Health Care Reform End?
November 25, 2009
The Health Care 'Trifecta'
Congress Ups the Pharma Ante for Health Reform
Protection for biotech innovation key to economic development
Gearing Up for Another Round in Healthcare Reform
Blue-chip biotechs maneuver to collect monopoly profits
November 24, 2009
Biotech bills give drugmakers too many years of exclusivity
Lobbyists spending big to shape health care debate
Fighting for patients' rights
Report: Lobbyists Help Write Rep. Lee Terry Speech
Health Care Hurdles
November 23, 2009
Yes, generics can cost more
Health care fight swells lobbying
Praying for healing, lobbying for a provision
Part D Coverage Gap Relief Added To Senate Health Reform Bill; Is It Enough?
Health Care Hurdles
November 20, 2009
PhRMa, Biotech Industry Apparently Untouched In Senate Bill
A leap forward to better care
Democrats Woo Voters With New Benefits
Senate Healthcare Bill Preserves Biologics Exclusivity, Drugmaker Fees
Showdown Set for Health Bill
November 19, 2009
HHS to warn consumers of flu drug price gouging
How Similar Are Biosimilars?
The Drug Industry Cashes In
Rising Prices of Drugs Lead to Call for Inquiry
Showdown Set for Health Bill
Obama's hurdle for biogenerics
November 18, 2009
Generic Drug Firm Makes a Case for Its Brand
Health Care Reform Could Be In Critical Condition If Senate Doesn't Vote By Christmas, Daschle Says
Monopoly on expensive, lifesaving drugs unfair
PhRMA hits back against NYT story
Inventing a Better Patent System
November 17, 2009
PCMA responds to drug price increase
White House healthcare accord with drug industry may be going sour
Puppets in Congress
Why Genentech lobbyists are worth every penny
Cha-ching! Drug makers get theirs while getting is good
November 16, 2009
Drug Makers Raise Prices in Face of Health Care Reform
In House, Many Spoke With One Voice: Lobbyists’
Seeking a Shorter Path to New Drugs
FTC Eyes Supply Dispute Between Drugmakers
Drug-Plan Costs Go Up
November 13, 2009
Washington's Gift to European Biotech
Why Is Small Business Opposed to the Health Care Bills?
The Life-and-Death Situation That Isn't
Groups Launch Anti-Health Care Reform Ads
Industry Seeks Specific FDA Guidance on Use of Social Media
November 12, 2009
Generic-Drug Makers Protest Supply Limits
Swinging The Ax At The Drug Companies
Drug industry presses FDA to allow more online ads
Health-Bill Battle Won't Get a Recess
FDA Officials Say Administrative Changes Will Speed Reviews Of Generics
November 11, 2009
Pharma Deal With White House on Course to Net Industry Billions
New Evidence of Pharma's Sweetheart Deal
Drugmakers don't see major U.S. reform boost
US health care sector is a fairly green giant
Healthcare reforms will cost U.S. states millions
November 10, 2009
Poll: Americans Divided on Health Care Overhaul
Republicans draw up follow-on biologics bill
With timing uncertain, focus shifts to Senate
House, Senate Health-Care Legislation: Side-by-Side Comparison
Generic Drugs' New Frontier
November 9, 2009
With timing uncertain, focus shifts to Senate
House, Senate Health-Care Legislation: Side-by-Side Comparison
Generic Drugs' New Frontier
November 6, 2009
AARP Throws Full Lobbying Weight Behind House Bill, But Still Seeks Biogenerics Compromise
Republican Healthcare Bill Contains 12-Year Biologic Exclusivity Period
Make it easy to create these generic drugs
At Top Schools, More Than Half the Profs Have Industry Ties
Merck Hunts for Biotech Acquisitions, Allies
November 5, 2009
Partnering Better Than Solo Play For Biosimilars, Says Dr. Reddy's CEO
Merck Hunts for Biotech Acquisitions, Allies
At Top Schools, More Than Half the Profs Have Industry Ties
Make it easy to create these generic drugs
Biologic drugs could face competition from generics
November 4, 2009
Healthcare legislation must address new class of drugs
Living On Biologics At $32,000 A Month?
House Health Care Bill Includes Biosimilar Licensure Pathway
Kickbacks Keeping Big Pharma Healthy?
Partnering Better Than Solo Play For Biosimilars, Says Dr. Reddy's CEO
November 3, 2009
Before We Pass Health Insurance Reform, We Must Do More to Limit Big Pharma's Monopoly on Biologics
Living On Biologics At $32,000 A Month?
Amid Obama barbs at Fox News, HMOs; PhRMA emerges as an unlikely Dem ally
Anna Eshoo's PhRMA Boondoggle: The Devil Is In Her Details
House Harder on Drug Makers Than Senate
November 2, 2009
High cost of living
Healthcare reform: ‘We’ve come too far to end it
Follow-On Biologics' Other Pathway: Mechanisms To Resolve Patent Disputes Vary In Legislation
Follow-on Biologics Data Exclusivity Debate Scorecard - Part III
Mixed Agendas Divide Health Coalition Effort
October 30, 2009
Drug Makers Face Tougher Measures
House Places Biosimilars, Brand Biologics In Same Billing Codes
Drug Office Not Weighing Administrative Options For Biosimilars
Follow-on Biologics Data Exclusivity Scorecard - Part II
Healthcare reform: ‘We’ve come too far to end it now’
October 29, 2009
Senate Healthcare Compromise Could Include Biosimilars
Innovators’ research data must be protected
Follow-On Biologic Data Exclusivity Debate Scorecard – Part 1
New York Times Spotlights AHIP, PhRMA Lobbyists
Health care reform needs to extend to drug prices
October 28, 2009
A Delicate Dance for 2 Health Lobbyists
Protecting Pharmaceutical Profits: The Cost Is Human Lives
Time Magazine on Data Exclusivity Debate
Doctors' Lobby in Tricky Spot
Commission to rein in federal entitlement costs is proposed
October 27, 2009
Paying For Health Reform: Drug Marketing Targeted In Senate Proposal
Innovations in Delivering Health Care
Europe: Go Easy on Your Pharma Lobbyists
AARP: Reform advocate and insurance salesman
Medicare Official Key to Spending
October 26, 2009
Bring down drug prices by lifting barriers to generics
Bleeding Biotech
Lobbyists figure heavily in biogenerics debate
Patients – and patience – in health care end game
Insurers poised to reap benefits from health care overhaul
October 23, 2009
Will Congress cover for a drug-maker’s billion-dollar mistake?
Biotech: The Influential Health-Care Lobby No One Talks About
Let’s reform lobbying next
US pharma lobbying bill soars
US Healthcare spending in 2008 reached US$2.3 trillion, while sales of pharmaceuticals topped US$309 billion
October 22, 2009
Opponents Try To Undo Health Bill Deals
How Drug Industry Lobbyists Got Their Way on Health Care
The Health Care Reform Corner
Drug Makers Are Advocacy Group’s Biggest Donors
October 21, 2009
A Little-Discussed Issue that Puts "Care" Back in Health Care Reform
Health-care lobbyists continue spending spree
Poll: Americans skittish over health changes
Spending on Health Lobbying Jumps in Third Quarter of Year
Groups To Push Senators On Affordability Of Coverage
October 20, 2009
PBMs' Recent Surge Could Have Long Run
Balancing the government's role on health care
Health Costs and History
October 19, 2009
CEOs Tally Health-Bill Score
Biotechs Back From The Dead
Some solutions already at hand
House, Senate Dems at odds on health care overhaul
GOP Launches Strategy to Trip Up Health Bill
White House has bad news for unions, tough talk for insurance companies
October 16, 2009
Dem officials set stage for corporate-backed health care campaign
NEJM Authors Say Five Years of Data Exclusivity Would Be Sufficient
Industries Launch Defensive
Senate Panel Passes Bill Limiting Generic Drug Deals
Health Blog: Critics Say 12 Years Is Too Long to Protect Biotech Drugs From Generics
As Big Pharma Eye Big Buyouts In India, Merck KGaA Goes With Bangalore Genei To Sharpen Its Edge In Biologics
October 15, 2009
Bill Thomas' Battle Plan For Cutting Biologics' 12-Year Exclusivity
Healthcare triumph gives way to heightened battle
Generic Drug Makers Say 'No' To Health Reform Tab
Health Blog: Critics Say 12 Years Is Too Long to Protect Biotech Drugs From Generics
Democrats Work to Finalize Health Legislation
October 14, 2009
Generics Seeks New Prescription for Influence
Healthcare Reform: Insurers Drop, Upside for Drug Makers?
Where things stand with health care overhaul
Snowe: Health care bill a 'good place to start'
Vermont's Prescriber Data Law Faces Tough Questions In Appeals Court
October 13, 2009
Selling Sickness: How Drug Ads Changed Health Care
The Early Word: The Health Care Vote
From foe to friend of reform
Health Care Votes: Where Key Committee Members Stand
Global pricing “hinders European arthritis drug access”
October 10, 2009
Patent Reform Bill Negotiations Accelerate; Hatch Wants No-Fault Re-Issues
Inside The Baucus Health Plan
Insurance Industry Opens Fire on Reform
Pro-Reform Lobbyists Express More Doubt On Baucus Bill
Flu Windfalls Boost Big Pharma
October 9, 2009
Hospira, Celltrion to Collaborate on Biogeneric Products
69 House Lawmakers Urge Pelosi To Keep Drug Price Negotiations In Health Reform Bill
Biogeneric drugs and brands: The future market share
Health-Care Tug of War Puts Patients In the Middle
Moderate Dems Wary Of CBO Numbers On Baucus Measure
October 8, 2009
McCain Seeks Drug Re-Importation Measure
Sebelius Calls Short Exclusivity Enough for Innovator Biologics
2010 Global Pharma Sales To Rise 4%-6%
The Biosimilars Debate: Is it Over?
A Phony Mail Order Controversy
Health Care Bill Gets Green Light in Cost Analysis
October 7, 2009
A cost-cutter that's missing in health bills
Pharma CEOs: Tax Soda, Cap Malpractice, Pay for Prevention
Swing Senators Wait on the CBO, Cast Doubts on Carper Plan
4 Senators’ Concerns Reflect Health Care Challenge
Lawmakers Offer Differing Views on Exclusivity at GPhA Event
Baucus Expects CBO Score Wednesday
October 6, 2009
In Debate on Health, It's Coverage vs. Cost
Rahm Shows His Pragmatic Ways in Deal with Prescription Drug Manufacturers
Bio Scores in Health Debate
Pfizer Wins While CVS Loses as Senate Weighs Obama Health Plan
It's Health Enrollment Time, and Premiums Likely to Rise
October 5, 2009
How To Cut Your Medical Bills
Medicare Bonuses Motivate More Physicians To E-Prescribe
How Healthcare Overhaul Could Affect Prescription Drug Plans
Health Overhaul Bill Inches Closer To House, Senate Floors
Sandoz Plans To Sell More Drugs In Japan, May Acquire Companies
October 2, 2009
Americans Upset By Industry Deals In Health Care Reform
PBM ‘Disclosure’ Gives Drugmakers and Drugstores Free Hand to Charge Higher Prices
Real Healthcare Reform Starts With Prescription Drug Reform
FDA Provides First Draft Guidance on REMS for Drugs, Biologics
Will Reform Cut Health Care Costs? Don't Bet on It
Also On the Net